CPA-7

CAS No. 16961-77-6

CPA-7 ( CPA 7;CPA7 )

Catalog No. M12586 CAS No. 16961-77-6

A platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CPA-7
  • Note
    Research use only, not for human use.
  • Brief Description
    A platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells.
  • Description
    A platinum-containing compound that disrupts STAT3 signaling, inhibits cell growth and induces apoptosis in STAT3-activated cancer cells; selectively and significantly inhibits Stat3 activation and DNA-binding activity, induces regression of colon tumors in mouse model at 5mg/kg, with the abrogation of persistent Stat3 activity in tumors.
  • Synonyms
    CPA 7;CPA7
  • Pathway
    JAK/STAT Signaling
  • Target
    STAT
  • Recptor
    STAT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    16961-77-6
  • Formula Weight
    381.50
  • Molecular Formula
    Cl3H6N3O2Pt
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    Platinum, diamminetrichloronitro- (8CI)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Turkson J, et al. Mol Cancer Ther. 2004 Dec;3(12):1533-42.
2. Assi HH, et al. J Pharmacol Exp Ther. 2014 Jun;349(3):458-69.
3. Littlefield SL, et al. Inorg Chem. 2008 Apr 7;47(7):2798-804.
4. Liang M, et al. BMC Cancer. 2016 Jul 19;16:504.
molnova catalog
related products
  • STAT3 inhibitor C188

    A potent, selective STAT3 inhibitor that blocks STAT3 binding to its phosphopeptide ligand (IC50=20 uM).

  • NSC 368262

    NSC 368262 is a selective STAT3 inhibitor that alkylates Cys468 in Stat3.

  • BP-1-102

    An orally bioavailable, small-molecule inhibitor of STAT3 with Kd of 504 nM.